Ticker

Analyst Price Targets — CNMD

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
May 1, 2025 1:26 pmMike MatsonNeedham$61.00$57.19TheFly Conmed price target lowered to $61 from $91 at Needham
October 4, 2024 9:04 amMike MatsonNeedham$97.00$66.59StreetInsider Needham Reiterates Buy Rating on CONMED (CNMD)
April 25, 2024 9:46 amMatt O\'BrienPiper Sandler$95.00$64.34StreetInsider CONMED (CNMD) PT Lowered to $95 at Piper Sandler
April 25, 2024 7:28 amMike MatsonNeedham$107.00$70.01StreetInsider CONMED (CNMD) PT Lowered to $107 at Needham
October 26, 2022 8:00 pmMatt O'BrienPiper Sandler$108.00$83.39TheFly Conmed price target lowered to $108 from $118 at Piper Sandler

Latest News for CNMD

CONMED Q4 Earnings Call Highlights

CONMED (NYSE: CNMD) reported fourth-quarter fiscal 2025 sales of $373.2 million, representing a 7.9% year-over-year increase as reported and 7.1% growth in constant currency, as management emphasized continued progress in orthopedics and improved supply conditions. For the full year, sales were $1.375 billion, up 5.2% as reported and 5.1% in constant currency. President and CEO Pat

Defense World • Jan 30, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CNMD.

House Trades Disclosures

NameTransaction DateTypeAssetAmountLink

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top